Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients.

@article{Dieplinger2016Interleukin6G,
  title={Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients.},
  author={Benjamin Dieplinger and Margot Egger and Isabella Leitner and Fritz Firlinger and Werner Poelz and Kurt Lenz and Meinhard Haltmayer and Thomas Mueller},
  journal={Journal of critical care},
  year={2016},
  volume={34},
  pages={38-45}
}
PURPOSE The aim of this study was to compare the prognostic value of interleukin 6 (IL-6), galectin 3, growth differentiation factor 15 (GDF-15), and soluble ST2 (sST2) in an unselected cohort of critically ill patients. METHODS During a study period of 1 year, we recruited 530 consecutive patients admitted to a medical intensive care unit of a tertiary care hospital. We examined a combination of inflammatory, renal, and cardiac biomarkers for the prediction of 90-day all-cause mortality… CONTINUE READING